Current Edition

clinical

NIH Opening First Mesothelioma Clinical Trial for Lynparza

The National Institutes of Health (NIH) in Bethesda, Maryland, is opening the first mesothelioma clinical trial involving the immunotherapy drug Lynparza (olaparib), a protein inhibitor …

Continue Reading →